Advertising

The Seattle Times Company

NWjobs | NWautos | NWhomes | NWsource | Free Classifieds | seattletimes.com

The Seattle Times

Business / Technology


Our network sites seattletimes.com | Advanced

Originally published January 8, 2007 at 12:00 AM | Page modified January 8, 2007 at 2:01 PM

E-mail article     Print view

Seattle Genetics shares jump on Genentech agreement

Seattle Genetics shares rose as much as 31 percent after the company agreed with Genentech Inc. to develop blood-cancer treatments.

Bloomberg

Seattle Genetics shares rose as much as 31 percent after the company agreed with Genentech Inc. to develop blood-cancer treatments.

Genentech will pay Seattle Genetics $60 million to co- develop an experimental treatment for multiple myeloma and other blood cancers, the companies said today.

Seattle Genetics, based in Bothell, may receive as much as $800 million from South San Francisco-based Genentech if the therapy, a so-called monoclonal antibody, passes certain development and sales guidelines for multiple diseases, the companies said in a statement.

Genentech's worldwide licensing agreement covers development and commercialization of SGN-40, Seattle Genetics' most advanced drug candidate. SGN-40 is currently in Phase I and Phase II clinical trials for multiple myeloma, chronic lymphocytic leukemia and non-Hodgkin's lymphoma.

Seattle Genetics shares increased by $1.35, or 26 percent, to $6.64 in mid-morning Nasdaq trading.

Seattle Times staff contributed to this report.

Copyright © 2006 The Seattle Times Company

More Business & Technology headlines...

E-mail article Print view      Share:    Digg     Newsvine

advertising

Retail Report: Pacific Place not ready to see J.Jill go

UPDATE - 12:12 PM
Google CEO: New operating system changes the game

UPDATE - 12:45 PM
GM exits bankruptcy; CEO vows better performance

AIG to pay millions in bonuses to top execs — again

UPDATE - 11:05 AM
Stocks falter as earnings jitters increase

Advertising

Video

AP Video

Entertainment | Top Video | World | Offbeat Video | Sci-Tech

Marketplace

 
Most read
Most commented
Most e-mailed
 
 
Advertising